Answer
Odevixibat sesquihydrate (Bylvay) has not been studied in patients with severe hepatic impairment (Child-Pugh C), and periodic liver function tests should be considered for these patients.
Sources for this answer
- Bylvay 200 micrograms hard capsulesIpsen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked